|
Volumn 36, Issue 5, 2004, Pages 1305-1307
|
Beneficial effect of concomitant induction with antilymphoblast globulin, cyclosporine, and steroids on long-term renal allograft outcome
a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CYCLOSPORIN;
LYMPHOBLAST ANTIBODY;
STEROID;
ADULT;
ARTICLE;
CAUSE OF DEATH;
CLINICAL FEATURE;
CLINICAL TRIAL;
CONFIDENCE INTERVAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CORRELATION ANALYSIS;
DIABETES MELLITUS;
DRUG EFFECT;
FEMALE;
GRAFT REJECTION;
GRAFT SURVIVAL;
HUMAN;
KIDNEY ALLOGRAFT;
KIDNEY TRANSPLANTATION;
LONG TERM CARE;
LOW DRUG DOSE;
MAJOR CLINICAL STUDY;
MALE;
MULTIVARIATE ANALYSIS OF COVARIANCE;
PATIENT SELECTION;
PREDICTION;
PRIORITY JOURNAL;
PROSPECTIVE STUDY;
RANDOMIZED CONTROLLED TRIAL;
RISK ASSESSMENT;
SENSITIVITY ANALYSIS;
STATISTICAL SIGNIFICANCE;
SURVIVAL RATE;
TECHNIQUE;
TREATMENT OUTCOME;
ADRENAL CORTEX HORMONES;
ADULT;
ANTILYMPHOCYTE SERUM;
CADAVER;
CYCLOSPORINE;
DRUG THERAPY, COMBINATION;
FEMALE;
FOLLOW-UP STUDIES;
GRAFT SURVIVAL;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY TRANSPLANTATION;
MALE;
REGRESSION ANALYSIS;
TIME FACTORS;
TISSUE DONORS;
TREATMENT OUTCOME;
|
EID: 3142602740
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/j.transproceed.2004.05.064 Document Type: Article |
Times cited : (3)
|
References (12)
|